Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury

Life Sciences

Volumn 79, Issue 1, 2006, Pages 38-44

  Arya, Dharamvir Singh ^a   Bansal, Pankaj ^a   Ojha, Shreesh Kumar ^a   Nandave, Mukesh ^a   Mohanty, Ipseeta ^a   Gupta, Suresh Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cardioprotection; Ischemia and reperfusion; Myocardial infarction; Pyruvate

Indexed keywords

ANTIOXIDANT; CREATINE KINASE MB; ISOENZYME; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HISTOPATHOLOGY; HYPOTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; RANDOMIZATION; RAT; REPERFUSION INJURY; TREATMENT DURATION;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CATALASE; CREATINE KINASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEART RATE; HEMODYNAMIC PROCESSES; LIPID PEROXIDATION; MALE; MUSCLE PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PYRUVIC ACID; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 33646522152     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.039     Document Type: Article

References (25)

1. Aebi H. UV-assay of catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Verlag Chemie, Weinheim, Germany 673-678
2. Bassenge E., Sommer O., Schwemmer M., and Bunger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) H2431-H2438
3. Bernier M., Hearse D.J., and Manning A.S. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circulation Research 58 (1986) 331-340
4. Bernier M., Manning A.S., and Hearse D.J. Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. American Journal of Physiology 256 (1989) H1344-H1352
5. Crestanello J.A., Kamelgard J., and Whitman G.J. The cumulative nature of pyruvate's dual mechanism for myocardial protection. Journal of Surgical Research 59 (1995) 198-204
6. Curello S., Ceconi C., Medici D., and Ferrari R. Oxidative stress during myocardial ischemia and reperfusion: experimental and clinical evidences. Journal of Applied Physiology 1 (1986) 311-327
7. Dobsak P., Courderot-Masuyer C., Zeller M., Vergely C., Laubriet A., Assem M., Eicher J.C., Teyssier J.R., Wolf J.E., and Rochette L. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. Journal of Cardiovascular Pharmacology 34 (1999) 651-659
8. Dormandy T.L. Free-radical oxidation and antioxidants. Lancet 8 (1978) 647-650
9. Ferrari R., Alfieri O., Curello S., Ceconi C., Cargnoni A., Marzollo P., Pardini A., Caradonna E., and Visioli O. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81 (1990) 201-211
10. Ferrari R., Guardigli G., Mele D., Percoco G.F., Ceconi C., and Curello S. Oxidative stress during myocardial ischemia and heart failure. Current Pharmaceutical Design 10 (2004) 1699-1711
11. Goldhaber J.I., and Weiss J.N. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 20 (1992) 118-127
12. Hearse D.J. Prospects for antioxidant therapy in cardiovascular medicine. American Journal of Medicine 91 (1991) 118S-121S
13. Jennings R.B., Murry C.E., Steenbergen Jr. C., and Reimer K.A. Development of cell injury in sustained acute ischemia. Circulation 82 (1990) II2-II12
14. Lamprecht W., Stan F., Weisser H., and Heinz F. Determination of creatine phosphate and adenosine triphosphate with creatine kinase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York 1776-1778
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
16. Mallet R.T., Squires J.E., Bhatia S., and Sun J. Pyruvate restores contractile function and antioxidant defenses of hydrogen peroxide-challenged myocardium. Journal of Molecular and Cellular Cardiology 34 (2002) 1173-1184
17. Maron M.S., Depierre J.W., and Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 582 (1979) 67-78
18. Misra H.P., and Fridovich I. The oxidation of phenylhydrazine: superoxide and mechanism. Biochemistry 15 (1976) 681-687
19. Mohanty I., Joshi S., Trivedi D., Srivastava S., Tandon R., and Gupta S.K. Pyruvate modulates antioxidant status of cultured human lens epithelial cells under hypergalactosemic conditions. Molecular and Cellular Biochemistry 238 (2002) 129-135
20. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
21. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70 (1967) 158-169
22. Reimer K.A., Vander-Heide R.S., and Richard V.J. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. American Journal of Cardiology 72 (1993) 13G-21G
23. Sevanian A., and Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annual Review of Nutrition 5 (1985) 365-390
24. 2+ transport. Archives of Biochemistry and Biophysics 387 (2001) 85-92
25. Wang Q.D., Pernow J., Sjoquist P.O., and Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovascular Research 55 (2002) 25-37